Diseases Affecting the
Pulmonary Circulation
Pulmonary Embolism
Perhaps the most serious and unpredictable condition affecting the pulmonary circulation is pulmonary embolism. It consists of occlusion of sections of the pulmonary arterial tree by thrombi carried in the bloodstream from the venous part of the circulation or from the right side of the heart. The sites of formation of thrombi vary. Whereas inflammatory diseases of the veins are usually associated with thrombosis (thrombophlebitis), pulmonary embolism occurs much more frequently in veins not affected by inflammation (phlebothrombosis). It is known that in susceptible persons thrombi can form in veins, particularly during periods of inactivity. The veins most commonly affected by "silent" thrombosis are deep veins of the legs (not varicose veins) and veins in the pelvic organs (reproductive organs in women and the prostate in men). Because inactivity is an important cause of such thrombi,
venous thrombosis and pulmonary emboli are particularly likely to develop in people who are bedridden.
Several types of pulmonary embolism can be distinguished. In pulmonary infarct a small single embolus affects a small segment of a lung, which becomes clogged with blood. This relatively benign condition may cause chest pain, spitting up of blood, and some fever; it appears on the chest X ray as a shadow similar to that of pneumonia. Prompt recovery usually occurs in a single infarct without sequelae. The significance of pulmonary infarct is as a predictor of larger, more serious emboli developing from the source of the small embolus.
A large pulmonary embolism or multiple emboli can cause overloading of the pulmonary circulation. When a certain area of the pulmonary arterial tree (usually more than half) is occluded by clots, pressure in the pulmonary artery rises. The sudden onset of pulmonary hypertension often does not give the heart time to adapt and rapidly leads to right ventricular failure. Such an event, occasionally referred to as acute cor pulmonale, can be fatal, but it may reverse itself when pulmonary emboli are no longer forthcoming, either because of cessation of thrombosis or in response to surgical intervention. Patients with acute cor pulmonale are short of breath, may be in shock, and show signs of right ventricular failure.
Massive pulmonary embolism occluding the main pulmonary artery or the two principal branches causes death, usually instantly and without warning. It is the prevention of this dreaded complication that has placed so much emphasis on signs of any disturbance of the venous circulation.
Small, repeated pulmonary emboli may feed the pulmonary circulation over a period of weeks, months, or years, causing gradual elevation of pressure in the pulmonary artery and leading to chronic, irreversible pulmonary hypertension. Fortunately uncommon, this severe, usually fatal form of pulmonary hypertension is almost indistinguishable from primary pulmonary hypertension.
Treatment of pulmonary embolism mainly involves anticoagulant therapy to prevent recurrences of emboli. Acute cases may call for thrombolytic therapy. Interventional therapy includes surgical removal of clots, located by angiography, from the pulmonary artery or its principal branches. Various methods of occluding the inferior vena cava in cases where emboli are thought to arise in the
lower part of the body are occasionally used. Occlusion blocks the pathway for emboli and forces the blood to return to the heart through small collateral veins.
Cor Pulmonale
The term "cor pulmonale" literally means heart disease related to the lungs or pulmonary circulation; it should logically include all disturbances of the pulmonary circulation. However, in current medical terminology the term "chronic cor pulmonale" is used exclusively to indicate the cardiac effect of chronic diseases of the lungs. "Acute cor pulmonale" has already been mentioned as referring to large pulmonary embolism, but there are some who question any use of the term "cor pulmonale" not connected with diseases of the lungs.
The essential feature of chronic cor pulmonale is pulmonary hypertension caused most frequently by hypoxemia. Thus cor pulmonale occurs when some parts of the lungs remain unventilated, though their blood supply is unimpaired, as in the late stages of pulmonary emphysema, pulmonary fibrosis, and some varieties of chronic bronchitis. Other, rarer conditions producing chronic hypoxemia include chronic mountain sickness (an exaggerated response in some persons to low oxygen content at high altitude) and extreme obesity. These two conditions are of course reversible— chronic mountain sickness by transferring the patient to a location at sea level, obesity by dieting. As a rule, however, chronic cor pulmonale is a serious condition indicating the late stages of lung disease. Treatment is limited to controlling heart failure and is usually ineffective.
Primary Pulmonary Hypertension
A rare, severe disease, primary pulmonary hypertension usually affects young adults and occasionally children; its cause is unknown. The onset of the disease is inconspicuous and its progress very slow, causing excessive fatigue and shortness of breath. Patients may live for several years partly incapacitated, but they eventually develop intractable heart failure. Treatment has little to offer: various drugs used for essential hypertension have been tried, but success, if any,
is only of short duration. In cases where there is even a suspicion that pulmonary hypertension may have been caused by repeated small emboli, anticoagulant therapy may arrest the progress of the disease, though significant improvement is uncommon.
Other Diseases Associated with
Pulmonary Hypertension
The conditions discussed above cause pulmonary hypertension, which is their primary link with heart disease. There are a number of diseases of the heart in which pulmonary hypertension develops secondarily and is only one of several factors affecting the heart. They include congenital heart disease, mitral stenosis and mitral insufficiency, and chronic failure of the left ventricle of the heart. These conditions may produce all three types of pulmonary hypertension—passive, hyperkinetic, and that related to high pulmonary vascular resistance. However, the first two types are less likely to cause severe pulmonary hypertension than the third. Consequently, in ordinary clinical terms the phrase "pulmonary hypertension" is most often applied to elevated pulmonary vascular resistance. Thus pulmonary hypertension in connection with mitral stenosis connotes that in addition to passive elevation of pressure in the pulmonary artery, arteriolar constriction has taken place. In congenital heart disease, separating operable cases with high flow (hyperkinetic) from inoperable cases with high resistance constitutes the basic problem (see chapter 11).